体重对复杂电生理干预的镇静相关结果的影响
Lyuboslav Katov1, Celine Dupree1, Yannick Teumer1
1Department of Cardiology, Ulm University Heart Center, Albert-Einstein-Allee 23, 89081 Ulm, Germany.
身体质量指数 (BMI) 在复杂的电生理学程序 (CEPs) 中没有影响镇静安全. 超重和肥胖患者的安全结果与正常体重患者相比,突出了需要个性化镇静方案的需要.
科学领域:
- 心脏病学 心脏病学
- 麻醉学 麻醉学
- 临床研究 临床研究
背景情况:
- 较高的体重指数 (BMI) 与心脏代谢并发症的增加有关,可能会增加与镇静有关的风险.
- 在复杂的电生理程序 (CEPs) 中,基于BMI进行镇静的安全性需要进一步调查.
研究的目的:
- 评估BMI与CEP期间镇静安全之间的关联.
- 为了确定BMI是否会影响CEP患者的镇静相关并发症的发生.
主要方法:
- 接受CEP的患者被分为正常体重,超重和肥胖的BMI组.
- 与镇静相关的并发症 (主要终点) 和镇静剂/阿片类药物需求 (次要终点) 用后勤回归分析.
- 并发症是由低氧和和特定的异常血液气体参数来定义的.
主要成果:
- 总共有726名患者在三个BMI组中进行了分析.
- 较高的BMI与更多的并发症和较低的基线氧和相关.
- 在BMI组之间没有发现主要或次要镇静终点的显著差异;女性性别是不良事件的独立预测因素.
结论:
- 单独的BMI并不是CEP期间与镇静有关的并发症的重要预测因素.
- 在CEP期间的程序安全性在正常体重,超重和肥胖患者中是可比的.
- 在标准化监测中,个性化镇静策略对于患者安全至关重要.
更多相关视频
10:19Induction of an Isoelectric Brain State to Investigate the Impact of Endogenous Synaptic Activity on Neuronal Excitability In Vivo
Published on: March 31, 2016
14:52Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers
Published on: January 13, 2018
相关概念视频
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Stages of General Anesthesia
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sedatives and Hypnotics Drugs: Barbiturates
Drug Dosing: Obese Patients
